Co-Diagnostics Joins April Trade Mission in Switzerland and Germany with Roche, UBS
Co-Diagnostics executives will join a European trade mission with Utah Governor Cox across Switzerland and Germany April 13–22, including site visits to Roche Diagnostics, UBS and Zurich Innovation Park. The initiative aims to expand its international network as it prepares a real-time PCR point-of-care platform for 510(k) FDA submission.
1. Trade Mission Overview
Co-Diagnostics executives will participate in a World Trade Center Utah trade mission led by Governor Cox from April 13 to 22, traveling across Switzerland and Germany. The delegation includes business, government and industry briefings designed to reinforce commercial, diplomatic and institutional ties in two of Europe’s leading economies.
2. Strategic Partnerships and Site Visits
The itinerary features site visits to Roche Diagnostics, UBS and Zurich Innovation Park, alongside academic and research institutions. Networking events aim to deepen relationships with strategic partners and explore new distribution channels in key European markets.
3. Product Pipeline Context
The mission coincides with Co-Diagnostics’ preparations for a FDA 510(k) submission of its real-time PCR point-of-care diagnostic platform and follows recent joint ventures in India and Saudi Arabia. Strengthening its international network supports the company’s global expansion strategy ahead of regulatory clearance and broader market rollouts.